Monthly Archives: October 2016

Thousands of melanoma patients in Europe have no access to new life saving drugs

Unacceptable inequalities in the availability and accessibility of new and effective cancer medications across Europe. Over 5000 patients with metastatic melanoma in Europe are denied access to new, life-saving drugs every year, according to a survey presented at the ESMO … Continue reading

Posted in Presentation | Tagged , | Leave a comment

Cancer treatment as a double-edged sword

Even with today’s safer and more targeted anti-cancer drugs, scientists have been unable to satisfactorily explain the phenomenon of why treated cancers so often recur. The common theory is that the cancer cell develops “internal resistance to treatment,” and overrides … Continue reading

Posted in Research | Tagged , , | Leave a comment